Compare Stocks: NMTC, SNWV, BEAT, and ELUT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.48 -1.7%	$0.47	$0.36 ▼ $4.00	$27.54M	-0.76	22.00 million shs	1.48 million shs
ELUT Elutia	$0.82 -0.5%	$0.85	$0.50 ▼ $1.39	$36.64M	0.84	435,492 shs	19,725 shs
NMTC NeuroOne Medical Technologies	$1.12 +3.7%	$1.56	$0.96 ▼ $6.42	$9.83M	0.77	186,676 shs	80,148 shs
SNWV Sanuwave Health	$5.62 -3.8%	$4.86	$3.92 ▼ $36.42	$50.28M	1.42	61,156 shs	23,439 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	-1.74%	+10.49%	+14.52%	-20.63%	-73.40%
ELUT Elutia	-0.51%	+5.70%	+2.87%	-14.53%	-7.41%
NMTC NeuroOne Medical Technologies	+3.70%	0.00%	-32.53%	-61.11%	-82.05%
SNWV Sanuwave Health	-3.77%	+16.60%	+39.11%	-51.88%	-82.06%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.48 -1.7%	$0.47	$0.36 ▼ $4.00	$27.54M	-0.76	22.00 million shs	1.48 million shs
ELUT Elutia	$0.82 -0.5%	$0.85	$0.50 ▼ $1.39	$36.64M	0.84	435,492 shs	19,725 shs
NMTC NeuroOne Medical Technologies	$1.12 +3.7%	$1.56	$0.96 ▼ $6.42	$9.83M	0.77	186,676 shs	80,148 shs
SNWV Sanuwave Health	$5.62 -3.8%	$4.86	$3.92 ▼ $36.42	$50.28M	1.42	61,156 shs	23,439 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	-1.74%	+10.49%	+14.52%	-20.63%	-73.40%
ELUT Elutia	-0.51%	+5.70%	+2.87%	-14.53%	-7.41%
NMTC NeuroOne Medical Technologies	+3.70%	0.00%	-32.53%	-61.11%	-82.05%
SNWV Sanuwave Health	-3.77%	+16.60%	+39.11%	-51.88%	-82.06%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BEAT HeartBeam	2.56	Moderate Buy	$4.00	732.99% Upside
ELUT Elutia	1.00	Sell	N/A	N/A
NMTC NeuroOne Medical Technologies	2.40	Hold	$7.33	554.76% Upside
SNWV Sanuwave Health	1.67	Reduce	$47.00	736.30% Upside

Current Analyst Ratings Breakdown

Latest NMTC, SNWV, BEAT, and ELUT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/8/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (E+)
10/6/2026	BEAT HeartBeam	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
9/29/2026	BEAT HeartBeam	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/22/2026	BEAT HeartBeam	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral
9/18/2026	SNWV Sanuwave Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
8/27/2026	SNWV Sanuwave Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
8/21/2026	NMTC NeuroOne Medical Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/18/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/14/2026	NMTC NeuroOne Medical Technologies	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$13.00 ➝ $5.00
8/11/2026	SNWV Sanuwave Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
7/28/2026	NMTC NeuroOne Medical Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BEAT HeartBeam	N/A	N/A	N/A	N/A	$0.06 per share	N/A
ELUT Elutia	$12.29M	2.97	N/A	N/A	$0.65 per share	1.27
NMTC NeuroOne Medical Technologies	$12.10M	0.84	N/A	N/A	$0.85 per share	1.32
SNWV Sanuwave Health	$44.02M	1.10	$1.63 per share	3.44	$0.19 per share	29.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BEAT HeartBeam	-$21.01M	-$0.51	N/A	N/A	N/A	N/A	-686.78%	-348.65%	11/12/2026 (Estimated)
ELUT Elutia	$53.38M	$0.95	0.87	N/A	N/A	426.93%	-407.37%	-47.08%	11/12/2026 (Estimated)
NMTC NeuroOne Medical Technologies	-$3.61M	-$0.95	N/A	N/A	N/A	-71.50%	-128.12%	-86.34%	12/15/2026 (Estimated)
SNWV Sanuwave Health	$11.81M	$0.24	23.42	N/A	N/A	32.38%	1,728.10%	39.04%	11/6/2026 (Estimated)

Latest NMTC, SNWV, BEAT, and ELUT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/6/2026	Q3 2026	SNWV Sanuwave Health	$0.01	N/A	N/A	N/A	$13.75 million	N/A
8/13/2026	Q2 2026	BEAT HeartBeam	-$0.0860	-$0.10	-$0.0140	-$0.10	$0.15 million	N/A
8/13/2026	Q2 2026	ELUT Elutia	-$0.15	-$0.17	-$0.02	-$0.17	$2.90 million	$2.43 million
8/13/2026	Q3 2026	NMTC NeuroOne Medical Technologies	-$0.21	-$0.28	-$0.07	-$0.28	$2.17 million	$1.97 million
8/6/2026	Q2 2026	SNWV Sanuwave Health	-$0.03	-$0.08	-$0.05	-$0.08	$11.50 million	$9.74 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BEAT HeartBeam	N/A	N/A	N/A	N/A	N/A
ELUT Elutia	N/A	N/A	N/A	N/A	N/A
NMTC NeuroOne Medical Technologies	N/A	N/A	N/A	N/A	N/A
SNWV Sanuwave Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BEAT HeartBeam	N/A	3.66	3.61
ELUT Elutia	N/A	1.77	1.64
NMTC NeuroOne Medical Technologies	N/A	2.84	1.71
SNWV Sanuwave Health	4.87	1.28	0.89

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BEAT HeartBeam	7.77%
ELUT Elutia	74.03%
NMTC NeuroOne Medical Technologies	16.07%
SNWV Sanuwave Health	42.53%

Insider Ownership

Company	Insider Ownership
BEAT HeartBeam	17.95%
ELUT Elutia	17.80%
NMTC NeuroOne Medical Technologies	11.80%
SNWV Sanuwave Health	14.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BEAT HeartBeam	1,700	56.35 million	46.23 million	Not Optionable
ELUT Elutia	180	44.29 million	36.41 million	Not Optionable
NMTC NeuroOne Medical Technologies	18	9.11 million	8.03 million	Optionable
SNWV Sanuwave Health	55	8.60 million	7.36 million	N/A

NMTC, SNWV, BEAT, and ELUT Headlines

Recent News About These Companies

Carlsmed (NASDAQ:CARL) versus Sanuwave Health (NASDAQ:SNWV) Financial Review

October 8 at 4:45 AM | americanbankingnews.com

Financial Contrast: Alphatec (NASDAQ:ATEC) vs. Sanuwave Health (NASDAQ:SNWV)

October 8 at 2:15 AM | americanbankingnews.com

Sanuwave Health (NASDAQ:SNWV) Stock Price Up 4.3% - What's Next?

October 3, 2026 | americanbankingnews.com

Eden Prairie medical device maker receives Nasdaq delisting notice

September 28, 2026 | bizjournals.com

SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from S&P Global BMI Index

September 21, 2026 | marketscreener.comM

SANUWAVE Health, Inc. (SNWV) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Sanuwave Announces Q2 FY2026 Financial Results

August 6, 2026 | globenewswire.com

Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 ...

July 30, 2026 | caledonianrecord.comC

Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results

July 30, 2026 | globenewswire.com

What's going on with SANUWAVE Health stock on Friday?

July 17, 2026 | msn.com

Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance

July 13, 2026 | globenewswire.com

SANUWAVE Health Earnings Estimates, EPS & Revenue | NASDAQ:SNWV

July 1, 2026 | benzinga.com

Sanuwave Health Updates Second Quarter 2026 Guidance

June 16, 2026 | globenewswire.com

SANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Record Revenue Amid Market Challenges

May 13, 2026 | finance.yahoo.com

SANUWAVE Health Balances Growth, Margin Pressure in Q1

May 13, 2026 | tipranks.com

Sanuwave (SNWV) Q1 2026 Earnings Transcript

May 13, 2026 | fool.com

SANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcript

May 13, 2026 | uk.finance.yahoo.com

SANUWAVE Health, Inc. (SNWV) Q1 2026 Earnings Call Transcript

May 13, 2026 | seekingalpha.com

Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates

May 12, 2026 | zacks.com

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

May 12, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NMTC, SNWV, BEAT, and ELUT Company Descriptions

HeartBeam NASDAQ:BEAT

$0.48 -0.01 (-1.74%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.47 -0.01 (-2.33%)

As of 10/9/2026 07:58 PM Eastern

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Elutia NASDAQ:ELUT

$0.82 0.00 (-0.51%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.80 -0.02 (-2.68%)

As of 10/9/2026 07:56 PM Eastern

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

NeuroOne Medical Technologies NASDAQ:NMTC

$1.12 +0.04 (+3.70%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$1.12 +0.00 (+0.18%)

As of 10/9/2026 07:30 PM Eastern

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Sanuwave Health NASDAQ:SNWV

$5.62 -0.22 (-3.77%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$5.62 0.00 (-0.09%)

As of 10/9/2026 07:30 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NMTC, SNWV, BEAT, and ELUT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NMTC, SNWV, BEAT, and ELUT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NMTC, SNWV, BEAT, and ELUT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NMTC, SNWV, BEAT, and ELUT Company Descriptions

HeartBeam NASDAQ:BEAT

Elutia NASDAQ:ELUT

NeuroOne Medical Technologies NASDAQ:NMTC

Sanuwave Health NASDAQ:SNWV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NMTC, SNWV, BEAT, and ELUT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NMTC, SNWV, BEAT, and ELUT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NMTC, SNWV, BEAT, and ELUT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NMTC, SNWV, BEAT, and ELUT Company Descriptions

HeartBeam NASDAQ:BEAT

Elutia NASDAQ:ELUT

NeuroOne Medical Technologies NASDAQ:NMTC

Sanuwave Health NASDAQ:SNWV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools